Literature DB >> 16088656

Management of cerebral perfusion pressure.

R Hlatky1, Y Furuya, A B Valadka, C S Robertson.   

Abstract

The management of cerebral perfusion pressure is among the most controversial treatment issues. Cerebral perfusion pressure (CPP) is normally expressed as the difference between mean arterial blood pressure and intracranial pressure and has two important physiological roles in the patient with severe head injury. First, CPP represents the pressure gradient acting across the cerebrovascular bed and hence is an important factor in the regulation of cerebral blood flow. Second, CPP contributes to the hydrostatic pressure within the intracerebral vessels, and therefore is one of the factors that determines edema formation in the injured brain. The border between adequate and inadequate CPP should be assessed individually and continuously, as it may fluctuate in time. The treatment plan that includes rapid identification of intracranial hemorrhage, rapid evacuation of extra-axial blood, treatment of intracranial hypertension, and promotion of cerebral and systemic perfusion is likely to provide the best outcome for all patients.

Entities:  

Year:  2001        PMID: 16088656     DOI: 10.1055/s-2001-13835

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  3 in total

1.  Partial aortic occlusion and cerebral venous steal: venous effects of arterial manipulation in acute stroke.

Authors:  Osvaldas Pranevicius; Mindaugas Pranevicius; David S Liebeskind
Journal:  Stroke       Date:  2011-03-24       Impact factor: 7.914

2.  Transcranial Doppler ultrasound goal-directed therapy for the early management of severe traumatic brain injury.

Authors:  Catherine Ract; Sophie Le Moigno; Nicolas Bruder; Bernard Vigué
Journal:  Intensive Care Med       Date:  2007-02-27       Impact factor: 17.440

3.  Intracranial multimodal monitoring for acute brain injury: a single institution review of current practices.

Authors:  R Morgan Stuart; Michael Schmidt; Pedro Kurtz; Allen Waziri; Raimund Helbok; Stephan A Mayer; Kiwon Lee; Neeraj Badjatia; Lawrence J Hirsch; E Sander Connolly; Jan Claassen
Journal:  Neurocrit Care       Date:  2010-04       Impact factor: 3.210

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.